EGFR and neoplasm: A facing challenge by liquid biopsies is the detection of EGFR mutations at extremely low concentrations of circulating tumour DNA (ctDNA) (<1% in many cases) in a background noise of much higher, but overall low concentrations of circulating free DNA (cfDNA) originated from elsewhere than the tumour cells of interest [25].